MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Stryker launches tender offer for Orthovita

Stryker launches tender offer for Orthovita

By

Stryker
Orthovita

Stryker Corp. (NYSE:SYK) launched its $3.85-per-share tender offer for Orthovita Inc. (NSDQ:VITA) as it looks to fill the void left by the sale of its troubled OP-1 assets.

Last week Stryker announced that it would pay $316 million in cash for Malvern, Pa.-based Orthovita, which makes a suite of products for the fusion, regeneration and fracture fixation of human bone, including Vitoss, a bone graft substitute, and Cortoss, a bone augmentation material. The offer is contingent on a majority of shareholdering tendering their stakes and is set to expire at midnight June 24.

The deal represents a 41 percent premium on VITA’s closing price of $2.73 per share May 13. It’s expected to close during the second quarter.

Stryker called the acquisition “highly complementary to Stryker’s existing orthobiologics offering” in a statement emailed to MassDevice.com.

Orthovita reported a $1.16 million loss on $23.7 million in sales during the three months ended March 31, compared with $1.18 million in losses on $24 million in sales during the same period last year. The company had just more than $59.7 million in assets at the end of the quarter, including $8.3 million in cash and equivalents.

Orthovita’s product line could potentially fill the hole left at Stryker by its offloaded its troubled OP-1 bone growth implants family to Japan-based Olympus Corp. for $60 million in December 2010.

The deal marked a a step towards Stryker freeing itself of the legal woes related to allegations it promoted the off-label combination of two of its bone growth products.

Federal investigators in Oct. 2009 indicted the company and four managers charging that they led a two-year campaign to promote the combined use of separate bone-healing products, each granted a narrow, provisional “humanitarian device exemption” by the FDA. Combining the treatments and devices — the OP-1 Implant, OP-1 Putty and the bone void filler Calstrux — caused adverse effects in patients ranging from minor irritations to infections requiring follow-up surgeries. The indictment also charged that Stryker and  former Stryker Biotech president Mark Philip lied to the FDA about the number of patients treated each year with OP-1 Putty.

The legal proceedings are still ongoing and in November federal prosecutors blasted Stryker Biotech, its former president and three sales reps for seeking the dismissal of the bulk of the 16 criminal charges pending against them in a federal case alleging the illegal promotion of the bone putties.

In case you missed it

RSS From Medical Design & Outsourcing

  • The best places to work for medtech sales reps
    Teleflex (NYSE:TFX), ConMed (NSDQ:CNMD) and orthopedic fixation company Acumed top the list of best places to work in medtech sales in the coming year, according to a MedReps.com survey of medical sales representatives. The 10th annual MedReps survey polled more than 2,000 medical sales professionals in October 2020 to get a better understanding of what employees look for… […]
  • Researchers tout probes for validating rapid COVID-19 tests
    Nanoengineers at the University of California San Diego have developed probes that they say could make validating rapid, point-of-care COVID-19 tests easier. The probes, called “positive controls,” are made from virus-like particles and are stable and easy to manufacture, according to a news release. The researchers at UCSD believe the positive controls can improve the… […]
  • How ResMed is advancing sleep and respiratory care
    The COVID-19 pandemic’s propulsion of widespread telehealth adoption has ResMed (NYSE:RMD) eyeing remote technologies for the next phase of its sleep and respiratory businesses. The president of that business for the San Diego-based company, Jim Hollingshead, told Medical Design & Outsourcing in a recent interview that the future lies with remote care and digital health offerings. “Right… […]
  • Stricter Documentation Requirements Pose New Challenges for Medical Device Manufacturers
    By Maurizio Lauria, Brand Manager, STEUTE Meditech Inc. New European guidelines and standards have greatly increased the testing and documentation required in order to introduce a new medical device, making the process even more complex and time-consuming for medical device manufacturers. Additionally, these standards apply not only to the device itself but the user interface,… […]
  • Tips to help bring your medical device from mind to market
    By Bret Ludwig, Ph.D. Senior Product Development Specialist, 3M Medical Materials & Technologies Great medical devices start with an idea—a spark. And from there, it might move to the back of a napkin or a notepad. But as development continues, the process can get trickier and more complex. In fact, turning an idea into a… […]
  • FDA allows dry heat treatment for single-user mask reuse
    The FDA has announced that it will allow the use of dry heat to lower the bioburden on masks used by healthcare workers treating COVID-19 patients. While not authorizing equipment made by a particular company, guidance released last week said healthcare providers may use dry heat to reprocess NIOSH-approved filtering facepiece respirators, such as N95s,… […]
  • Mass General researchers tout low-cost, portable brain imaging scanner
    Researchers at Massachusetts General Hospital are touting a low-cost, portable “head only” MRI scanner that could be used in multiple settings. As opposed to standard costly, immobile MRI scanners that require special infrastructure, the MGH researchers developed a low-cost, compact, portable and low-power scanner that could be mounted in an ambulance, wheeled into a patient’s… […]
  • HHS confirms involvement in presidential transition process
    U.S. Health and Human Services Dept. Secretary Alex Azar confirmed that HHS is working with president-elect Joe Biden on a presidential transition. Speaking during a press briefing, Azar said HHS is in contact with the transition team after the General Services Administration formally recognized Biden as the president-elect, having previously sidestepped questions regarding the potential… […]
  • Swiss scientists make ‘micromachines’ for self-deploying stents and more
    Researchers in Zurich reported today that they have invented a manufacturing technique to build “micromachines” out of metal and plastic in which these two materials are interlocked as closely as links in a chain. These robots are so tiny that they can maneuver through blood vessels and deliver medications to certain points in the body… […]
  • This AI algorithm could detect COVID-19 in chest X-rays
    Northwestern University researchers are touting a new AI platform that can detect COVID-19 in X-ray images of the lungs. DeepCOVID-XR, a machine-learning algorithm, performed better than a team of specialized thoracic radiologists by spotting COVID-19 in X-rays about 10 times faster and 1%-6% more accurately, according to a news release. Researchers involved think physicians could… […]
  • Aspen Surgical acquires Protek Medical Products
    Disposable products maker Aspen Surgical Products today announced the acquisition of Protek Medical Products (Coralville, Iowa). Protek manufactures single-use ultrasonic probe covers and needle guides used in tissue biopsies, fluid aspiration, and vascular access procedures as well as protective covers for medical instruments and equipment. The acquisition of Protek strengthens Aspen’s portfolio of medical, patient… […]

Leave a Reply